New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients (Q42024592)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 1986
edit
Language Label Description Also known as
English
New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients
scientific article published on October 1986

    Statements

    New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients (English)
    1 October 1986
    1085-1089

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit